SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-198000
Filing Date
2014-05-14
Accepted
2014-05-14 07:03:23
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d703445d10q.htm 10-Q 301766
2 EX-31.1 d703445dex311.htm EX-31.1 5769
3 EX-32.1 d703445dex321.htm EX-32.1 2991
  Complete submission text file 0001193125-14-198000.txt   2909887

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxii-20140331.xml EX-101.INS 329527
5 XBRL TAXONOMY EXTENSION SCHEMA rxii-20140331.xsd EX-101.SCH 26076
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20140331_cal.xml EX-101.CAL 42479
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20140331_def.xml EX-101.DEF 148718
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20140331_lab.xml EX-101.LAB 272234
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20140331_pre.xml EX-101.PRE 204649
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 14839181
SIC: 2834 Pharmaceutical Preparations